Skip to main content

RHUMBLINE ADVISERS

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1115418 BOSTON, MA

Position in SUPN

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$8,749,824
+$581,629 QoQ
Shares Held
169,275
+3.0% QoQ
Ownership
0.292%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 42.58514251956875.ToString("F0")% Shared 0.ToString("F0")% None 57.414857480431245.ToString("F0")%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $438,094,582 across 50 Drug Manufacturers - Specialty & Generic names. SUPN ranks #10 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SUPN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $8,749,824 169,275
2025-12-31 $8,168,195 164,350
2025-09-30 $8,114,837 169,802
2025-06-30 $5,428,689 172,230
2025-03-31 $5,414,328 165,323
2024-12-31 $6,235,575 172,444
2024-09-30 $5,351,859 171,644
2024-06-30 $4,822,329 180,274
2024-03-31 $5,950,864 174,461
2023-12-31 $5,143,245 177,721
2023-09-30 $4,591,618 166,544
2023-06-30 $4,947,214 164,578
2023-03-31 $6,302,788 173,966
2022-12-31 $5,883,802 164,951
2022-09-30 $5,460,140 161,304
2022-06-30 $4,461,257 154,262
2022-03-31 $4,794,025 148,330
2021-12-31 $4,223,913 144,853
2021-09-30 $3,919,369 146,958
2021-06-30 $5,086,631 165,204
2021-03-31 $4,364,808 166,723
2020-12-31 $4,081,002 162,202
2020-09-30 $3,190,562 153,098
2020-06-30 $4,096,162 172,470
2020-03-31 $3,021,168 167,936